Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability

Junhang Zhang1, Renhai Cao, Yun Zhang

  • 1Division of Vascular Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-17176, Stockholm, Sweden.

Insights

Combining platelet-derived growth factor AB (PDGF-AB) with fibroblast growth factor 2 (FGF-2) promotes stable blood vessel growth. This combination effectively treats ischemic diseases by enhancing vascularization and perfusion in animal models.

Area of Science:

  • Regenerative Medicine
  • Vascular Biology
  • Biotechnology

Background:

  • Previous attempts to treat ischemic conditions with single proangiogenic factors have shown limited success.
  • Stable and functional arterial networks may necessitate the combined action of multiple angiogenic and arteriogenic factors.

Purpose of the Study:

  • To compare the angiogenic and therapeutic effects of fibroblast growth factor 2 (FGF-2) combined with platelet-derived growth factor (PDGF)-AA or PDGF-AB.
  • To investigate the role of PDGF receptor beta (PDGFR-beta) in vascular stability.

Main Methods:

  • In vivo angiogenesis assays (mouse cornea model) and ischemic hind-limb models in rats.
  • Evaluation of vascular network formation, collateral growth, and tissue perfusion.
  • Immunohistochemical analysis to assess cellular recruitment and marker expression.

Main Results:

  • Both PDGF-AA/FGF-2 and PDGF-AB/FGF-2 combinations synergistically induced angiogenesis.
  • PDGF-AB/FGF-2 promoted vascular stability by recruiting pericytes, a process dependent on PDGFR-beta.
  • PDGF-AB/FGF-2 significantly improved perfusion and induced stable collateral growth in ischemic hind limbs.

Conclusions:

  • PDGF-AB in combination with FGF-2 is an optimal therapeutic strategy for promoting stable arteriogenesis in ischemic tissues.
  • PDGFR-beta signaling is crucial for achieving stable neovasculature.
  • This combination therapy holds promise for treating ischemic diseases.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...